Progelife Overview

  • Founded
  • 2014

  • Status
  • Private

  • Employees
  • 10

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $881K

  • Investors
  • 1

Progelife General Information


Operator of a biotechnology company intended to develop drugs for the treatment of rare genetic aging diseases. The company designs patented therapeutics whose molecules are identified and validated for rare genetic diseases and are transposed to more frequent pathologies linked to the generalized aging of the population, enabling children and patients suffering from certain skin cancers to get proper treatments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 61 Boulevard des Dames
  • 13002 Marseille
  • France

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Progelife Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 03-Mar-2020 $881K 00.000 000.00 Completed Generating Revenue
2. Seed Round 08-Mar-2019 00000 00000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Progelife’s complete valuation and funding history, request access »

Progelife Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 0.000
To view Progelife’s complete cap table history, request access »

Progelife Executive Team (5)

Name Title Board Seat Contact Info
Frederic Beneton Chief Executive Officer, Managing Director & President
Pierre Cau Ph.D Co-Founder & Scientific Director
Eric Dessaud Ph.D CSO
Nicolas Lévy Ph.D Co-Founder
You’re viewing 4 of 5 executive team members. Get the full list »

Progelife Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Progelife Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Incubateur Impulse Accelerator/Incubator 000 0000 000000 0
To view Progelife’s complete investors history, request access »